Difference Between Insulin Resistance and Type 2 Diabetes Symptoms

Jun 9, 2026

Quick answer: Insulin resistance is the long, quiet stage that comes years to decades before type 2 diabetes. The crucial difference: in insulin resistance your blood sugar still looks normal — your pancreas is just working overtime, pumping out extra insulin to keep it there. In type 2 diabetes the pancreas can no longer keep up, so blood sugar finally rises and the familiar symptoms appear. The catch is that a standard "fasting glucose + HbA1c" test can look perfectly fine for 10–20 years while insulin resistance silently builds. The two ways to catch it early: ask for a fasting insulin test (not just glucose), and learn the visible skin signs most people never connect to blood sugar.

Written by Aarti Laxman, Co-Founder & Chief Nutrition Officer, Artinci — Certified in Low-Carb Nutrition & Metabolic Health (CPD UK) · Last updated June 2026

I've worn a continuous glucose monitor for years and I test my own fasting insulin regularly — not because anything is wrong, but because I come from a family where diabetes was treated as inevitable, and I wanted to see trouble coming long before it arrived. What I've learned is that the standard tests most Indians get miss the earliest, most important stage entirely. Let me show you what to look for.

The key difference: silent build-up vs. active disease

Insulin resistance is the warning stage. Your cells stop responding well to insulin, so your pancreas compensates by making more of it. That extra insulin succeeds in keeping your blood sugar normal — which is exactly why it's so easily missed. You feel fine. Your sugar reading looks fine. But behind the scenes, insulin is running high and metabolic strain is accumulating.

Type 2 diabetes is the crisis stage. After years of overwork, the pancreas can no longer produce enough insulin to overcome the resistance. Blood sugar finally climbs past the diabetes line (a fasting glucose of 126 mg/dL or more), and the classic symptoms — frequent urination, intense thirst, fatigue, blurred vision — show up.

Think of it like a bridge under slowly increasing load. Insulin resistance is the years of quiet stress on the structure when everything still looks fine from the outside. Diabetes is when the cracks finally become visible. The whole point of this article is to help you read the early stress — not wait for the cracks.

Why insulin resistance is so easy to miss

Here's the honest truth that trips up even careful people: in its early stage, insulin resistance usually causes no symptoms you can feel. There's no reliable "I'm tired so it must be insulin resistance" signal — fatigue and sugar cravings are far too common and non-specific to diagnose anything. The only dependable way to know what your insulin is doing is to measure it.

Feature Insulin resistance (early) Type 2 diabetes
Symptoms you feel Usually none Frequent urination, extreme thirst, fatigue, blurred vision
Fasting blood sugar Normal — but held there by high insulin High (126 mg/dL or above)
Fasting insulin Often already elevated High early, then may fall as the pancreas tires
Visible signs Skin changes (see below), increasing belly fat Slow-healing wounds, frequent infections
Best detected by Fasting insulin + HOMA-IR Fasting glucose + HbA1c
Stage Warning — most reversible Established disease

Notice what's not in the insulin-resistance column: thirst, heavy urination, hunger. Those belong to diabetes, once sugar is already high. If you're looking for them as early warnings, you'll miss your window — because by the time they appear, you've usually crossed into diabetes.

The surprising part: insulin resistance is often visible on your skin

This is the section I most want you to remember, because almost nobody connects these dots. Insulin resistance isn't entirely silent — it can leave clues on your skin, years before your glucose ever moves. The reason is beautifully simple: when insulin runs high, it doesn't only act on blood sugar. Excess insulin also switches on growth receptors in the skin (called IGF-1 receptors), telling skin cells to multiply. The result is two tell-tale signs:

  • Acanthosis nigricans — patches of dark, velvety, slightly thickened skin, usually in body folds: the back and sides of the neck, the armpits, the groin. People often mistake it for dirt that won't wash off, or a tan. It isn't either. In a younger person especially, it's one of the most reliable visible markers of high insulin.
  • Skin tags (acrochordons) — small, soft, flesh-coloured growths, classically appearing in clusters on the neck and armpits. The odd single skin tag is harmless and common. But a sudden crop of several, in those friction areas, is strongly linked to high insulin. Dermatologists sometimes call acanthosis nigricans and skin tags the "twin signs" of insulin resistance.

Here's the empowering part: because these signs are caused by high insulin, they often fade or regress as insulin sensitivity improves — with weight loss, exercise and a lower-sugar diet. So they're not just a warning; they're a visible scorecard of your progress. If you have either of these, it's not a diagnosis — but it's a strong reason to get the blood test in the next section.

The test most people never get: fasting insulin

If there's one practical thing to take from this article, it's this: ask your doctor for a fasting insulin test, alongside your usual fasting glucose and HbA1c. Here's why it matters so much.

Fasting glucose and HbA1c measure blood sugar — and sugar is the thing that stays normal until late in the process. Fasting insulin measures the effort your body is making to keep that sugar normal. In the long compensatory phase, insulin rises first — often 10 to 20 years before glucose or HbA1c ever look abnormal. It is, in plain terms, the earliest widely available warning light on the dashboard.

The trap in the "normal" range. Most labs report a fasting insulin reference range of roughly 2.5 to 25 µIU/mL and call anything inside it "normal." But that range comes from the general population — a population already full of people with undiagnosed insulin resistance. So a reading of 18 or 20 gets stamped "normal" while actually signalling significant strain. Metabolic-health specialists use a much tighter, more protective target:

  • Under 6 µIU/mL — the optimal zone metabolic-health practitioners aim for; suggests your body keeps sugar steady without much effort.
  • Roughly 7–12 µIU/mL — an early-warning grey zone, even though the lab still says "normal."
  • Above ~12 µIU/mL — high; consistent with insulin resistance, whatever the lab range claims.

(These tighter targets come from functional and metabolic-health practice, not from an official diagnostic cut-off — so treat under-6 as a goal for excellent metabolic health, and discuss your specific result with your doctor.)

HOMA-IR — the combined score. Your doctor can also calculate a single insulin-resistance score from the two fasting numbers: HOMA-IR = (fasting insulin × fasting glucose in mg/dL) ÷ 405. It's a simple, useful way to track whether you're moving in the right direction over time.

Why this matters more — and earlier — for Indians

This isn't a copy-paste of Western advice, because South Asian bodies behave differently, and the standard thresholds can give false reassurance. Three things stack against us:

  • Insulin resistance at a lower body weight. South Asians tend to develop insulin resistance at a lower BMI than Europeans. You can look slim by the usual yardstick and still be metabolically strained.
  • The "thin-fat" pattern. We tend to carry more visceral fat — the deep fat around the abdominal organs that drives insulin resistance — even when limbs and overall weight look normal. A flat-looking frame with a soft belly is the classic at-risk shape.
  • Younger onset. Type 2 diabetes shows up a decade or more earlier in Indians than in many Western populations, which means the insulin-resistance window opens earlier too — often in the 30s.

Because of this, the waist thresholds that matter for Indians are lower than the old US numbers. Use the South Asian cut-offs:

  • Men: waist above ~90 cm (about 35 inches) signals raised risk.
  • Women: waist above ~80 cm (about 31–32 inches) signals raised risk.

If you've been told "your weight is fine" but your waist is past these marks — or you have the skin signs above — that's reason enough to ask for the fuller blood panel.

What to actually get tested

If you have a family history of diabetes, increasing belly fat, the skin signs above, or you're simply over 30 and want a real baseline, ask for:

  1. Fasting insulin — the early-warning marker (target under ~6 µIU/mL for optimal metabolic health).
  2. Fasting glucose — normal is under 100 mg/dL; 100–125 is prediabetes; 126+ is diabetes.
  3. HbA1c — under 5.7% is normal; 5.7–6.4% is prediabetes; 6.5% or above is diabetes (ADA).
  4. HOMA-IR — the combined insulin-resistance score, tracked over time.
  5. Triglycerides and HDL — high triglycerides with low HDL is a classic insulin-resistance fingerprint.
  6. Waist measurement — using the South Asian cut-offs above.

The good news: the early stage is the workable stage

Catching insulin resistance early genuinely changes the trajectory — and this is where the effort pays off most. In the landmark Diabetes Prevention Program, people at high risk who lost around 7% of their body weight and added regular physical activity cut their progression to type 2 diabetes by roughly 58% — more effectively than medication did in the same trial. Early insulin resistance can often be substantially improved, and in many cases sent into remission, with the same levers: losing visceral fat, moving more, building muscle, and lowering the sugar and refined-carb load of your meals.

To be honest and careful about the language: this isn't a guaranteed "cure," and once established type 2 diabetes sets in, improvement is harder and usually needs medical support. That's precisely the argument for acting at the insulin-resistance stage, while the window is widest. None of this replaces your doctor — it's the conversation to walk in and have.

The bottom line

Insulin resistance is the silent, years-long build-up; type 2 diabetes is the visible crisis at the end of it. Don't wait for thirst and frequent urination — those are late signs. Instead, watch for the velvety dark patches and clusters of skin tags, mind the South Asian waist cut-offs, and ask for the one test that sees trouble first: fasting insulin. The earlier you look, the more you can do.

Frequently asked questions

What is the main difference between insulin resistance and type 2 diabetes?

In insulin resistance, blood sugar is still normal because the pancreas makes extra insulin to keep it there — so standard sugar tests look fine. In type 2 diabetes, the pancreas can no longer keep up, blood sugar rises above the diabetes threshold (126 mg/dL fasting), and symptoms like thirst and frequent urination appear. Insulin resistance is the earlier, more reversible warning stage.

Can you have insulin resistance with normal blood sugar?

Yes — that is the defining feature of early insulin resistance. The pancreas compensates by producing more insulin, which keeps fasting glucose and HbA1c normal for 10–20 years. This is why a fasting insulin test, which detects the high insulin directly, catches the problem far earlier than sugar tests alone.

What are the skin signs of insulin resistance?

The two main ones are acanthosis nigricans (dark, velvety, thickened patches in body folds like the neck, armpits and groin) and clusters of skin tags (acrochordons) in those same friction areas. Both are caused by high insulin stimulating skin-cell growth, and they often fade as insulin sensitivity improves with diet, exercise and weight loss.

What should my fasting insulin level be?

Standard labs call a fasting insulin of roughly 2.5–25 µIU/mL "normal," but that range hides early insulin resistance. Metabolic-health specialists aim for under about 6 µIU/mL as optimal; 7–12 is an early-warning grey zone and above ~12 is consistent with insulin resistance. This is a metabolic-health goal rather than an official diagnostic cut-off, so discuss your result with your doctor.

Why are Indians at higher risk of insulin resistance?

South Asians tend to develop insulin resistance at a lower BMI, carry more visceral (deep abdominal) fat even when slim — the "thin-fat" pattern — and develop type 2 diabetes about a decade earlier. Because of this, lower waist cut-offs apply: about 90 cm (35 inches) for men and 80 cm (31–32 inches) for women.

Can insulin resistance be reversed?

Early insulin resistance can often be substantially improved or put into remission through losing visceral fat, regular activity, building muscle and lowering dietary sugar and refined carbs. In the Diabetes Prevention Program, about 7% weight loss plus activity cut progression to diabetes by roughly 58%. It is not a guaranteed cure, and established diabetes is harder to reverse — which is the case for acting early.

The takeaway: the earlier you catch insulin resistance, the more your daily choices matter — and lowering the sugar load of your meals is one of the simplest levers. It's why we make sugar-free Indian sweets: so a daily treat can fit a metabolically careful life instead of working against it.

This article is for general education and is not medical advice. Test interpretation and targets vary by individual; discuss your results and any testing decisions with a qualified healthcare professional.

Sources

  • American Diabetes Association — Understanding Insulin Resistance and HbA1c diagnostic criteria
  • CDC — About Insulin Resistance and Type 2 Diabetes
  • Cleveland Clinic — Insulin Resistance: causes, symptoms & management
  • Barbato MT et al. — Association of acanthosis nigricans and skin tags with insulin resistance, An Bras Dermatol, 2012 (PMID 22481657)
  • Skin manifestations of insulin resistance (acanthosis nigricans and acrochordons), Postgraduate Medical Journal review, 2020 (PMID 31611265)
  • Reaven GM — Banting Lecture: role of insulin resistance in human disease, Diabetes, 1988 (PMID 3056758)
  • Knowler WC et al. — Diabetes Prevention Program: reduction in the incidence of type 2 diabetes with lifestyle intervention, New England Journal of Medicine, 2002
  • Zhang C et al. — fasting insulin / HOMA-IR and mortality, prospective cohort meta-analysis, 2017

Explore more